IDCU HomeInfectious Diseases A-CD-GH-LM-QR-ST-ZIDCU Health TopicsDisease ReportingRelated Rules & RegulationsImmunization BranchAbout IDCURelated DSHS SitesStaff Contact List
  • Contact Us

    TB and Refugee Health Services Branch

    MC 1939
    P.O. Box 149347
    Austin, TX 78756-9347

    Phone: 512-533-3000
    Fax: 512-533-3167

    Email the TB Program

TB Control Standards

Standards for TB Prevention and Control

FY 2016 Texas Tuberculosis Work Plan (Adobe PDF File 2.1 MB)
Notice of Change in TB Personnel (Adobe PDF File 67 KB)

Standing Delegation Orders (FY2016)





Signed Memorandum for Standing Delegation Orders (SDO) and Standing Medical Orders for TB Prevention and Control

Adobe PDF File   77 KB

SDO Question and Answer Session Document Adobe PDF File 237 KB 8-13-15

Tuberculosis Clinical Services Provided by Registered Nurses and Licensed Vocational Nurses

Adobe PDF File 975 KB
Microsoft Word File 251 KB


Tuberculosis Blood Specimen Collection Services Provided by Non-Licensed Staff

Adobe PDF File 370 KB
Microsoft Word File 39 KB


Tuberculosis Directly Observed Therapy Services Provided by Non-Licensed Staff

Adobe PDF File 353 KB
Microsoft Word File  43 KB


Tuberculosis Sputum Collection Services Provided by Non-Licensed Staff

Adobe PDF File 362 KB
Microsoft Word File 47 KB


Tuberculosis Tuberculin Skin Testing Services Provided by Non-Licensed Staff

Adobe PDF File 410 KB
Microsoft Word File 57 KB



TB Policies and Procedures         

TB Policies and Procedures
Policy Name File



Standing Delegation Orders and Procedures for TB Prevention and Control Adobe PDF File 26 KB 9-01-13
TB-1002 Frequency of Tuberculin Skin Testing for Tuberculosis Infection for Adults in Various Settings Adobe PDF File 60 KB 6-26-08
TB-1003 Tuberculin Skin Testing Guidelines for Children in Various Settings Adobe PDF File 77 KB 6-26-08
TB-1004 Anergy Testing Adobe PDF File 26 KB 6-26-08
TB-4002 Drug Resistance Adobe PDF File 141 KB 6-26-08
TB-5001 Directly Observed Therapy for Active TB Disease and Latent TB Infection Adobe PDF File 47 KB 6-26-08
7000 Cohort Review Policy Adobe PDF File 46 KB 3-09-15
  TB/HIV/STD Security Policies and Procedures    

Back to Top


CDC Recommendations and Guidelines, by category

Current CDC publications for the prevention and control of TB organized by the following categories:


Control and Elimination

These guidelines and recommendations address the obstacles and opportunities for controlling and eliminating TB in the United States, including the essential components of TB prevention and control programs, and the need to address TB in low-incidence areas of the United States and in communities with at-risk minority populations.


These diagnostic standards provide a practical guide and statement of principles for all persons involved in the care of patients with TB.  They cover transmission of mycobacterium tuberculosis, clinical manifestations of TB, diagnostic microbiology, tuberculin skin test, definitions of TB disease and latent infection, and treatment of TB and TB infection. 


These guidelines update previous CDC recommendations for the diagnosis, treatment, and prevention of TB among adults and children coinfected with HIV in the United States. 

Infection Control

Transmission of mycobacterium tuberculosis is a risk for patients and health care workers in healthcare facilities.  These guidelines recommend strategies for reducing this risk in healthcare facilities.

Multidrug-Resistant TB (MDR)

Outbreaks of multidrug-resistant TB (MDR) pose a public health problem and require rapid attention.  These guidelines present an action plan to specifically address this problem and cover the management of persons exposed to MDR.


Targeted tuberculin testing for latent tuberculosis infection (LTBI) is a strategic component of TB control that identifies persons at high risk for TB who would benefit by treatment of LTBI, if detected.  These guidelines provide new recommendations for targeted tuberculin testing and treatment regimens for LTBI.  Guidelines are also given to screening for TB and TB infection in high-risk populations.


These guidelines address treatment regimens for TB among adults, children, persons coinfected with HIV, persons exposed to MDR, and LTBI.


These guidelines discuss the role of vaccines in TB prevention and control in the United States. Bacillus of Calmette and Guerin (BCG) is not recommended for programmatic use in the United States. Recognizing the importance of TB vaccines, the ACET recommends that public agencies and vaccine manufacturers develop a comprehensive strategy for new TB vaccine development.

All categories

View a list of all categories for which the CDC has issued guidelines and recommendations for the prevention, treatment, and control of TB.

Back to Top

CDC TB Publications

Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection
From CDC's MMWR Weekly; December 9, 2011 / 60(48);1650-1653

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010
From CDC's MMWR Recommendations and Reports; June 25, 2010 / 59(RR05);1-25

Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
From CDC's MMWR Weekly; January 16, 2009 / 58(01);7-10

Plan to Combat Extensively Drug-Resistant Tuberculosis
From CDC's MMWR Recommendations and Reports; February 13, 2009; 58 (RR-03); 1-43

CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment (PDF)
From CDC

Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC
From CDC’s MMWR Recommendations and Reports 2006; July 7, 2006 / Vol. 55 (RR09); 1-44

Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
From CDC's MMWR Recommendations and Reports; December 16, 2005; 54(No. RR-15): 49—55.

Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis
From Centers for Disease Control and Prevention's (CDC) MMWR Recommendations and Reports: December 16, 2005 / Vol. 54(RR15): 1-37

Controlling Tuberculosis in the United States – Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
From CDC’s MMWR: November 4, 2005 / Vol. 54(RR12): 1-81

Guidelines for Preventing the Transmission of Mycobacterium tuberculosisin Health-Care Settings, 2005
From CDC’s MMWR Recommendations and Reports
, December 30, 2005 / Vol. 54 (RR17); 1-141

Slide Set — Guidelines for Preventing the Transmission of M. tuberculosis in Health-Care Settings, 2005

Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC
From CDC’s MMWR Recommendations and Reports 2005; December 16, 2005 / Vol. 54 (RR15)/ 1-37

Treatment of Tuberculosis
American Thoracic Society, CDC, and Infectious Diseases Society of America
MMWR: June 20, 2003 / Vol. 52 (RR11): 1-77

Appendix B-Tuberculosis (TB) risk assessment worksheet )

TB Guidelines
From DTBE, a listing of all TB Guidelines issued from the division

Progressing Toward Tuberculosis Elimination in Low-Incidence Areas of the United States - Recommendations of the Advisory Council for the Elimination of Tuberculosis
From CDC’s MMWR Recommendations and Reports: May 3, 2002 / Vol. 51 (RR05);1-16

Diagnostic Standards/Classification of TB in Adults and Children (PDF)
American Journal of Respiratory Care and Critical Care Medicine, 2000; Vol. 161:1376-1395.


Back to Top

Last updated January 26, 2016